Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5891

Verzenio's survival benefit in early breast cancer; Another RemeGen Phase 3 win

$
0
0
Plus, news about Nykode, Therna Biosciences, Fosun, Sitala Bio, Catalyst Pharmaceuticals and Lupin: 🔎 Lilly’s Verzenio improves survival in early breast cancer: In the seven-year analysis of the monarchE trial, two years of treatment ...

Viewing all articles
Browse latest Browse all 5891

Trending Articles